Default company panoramic image

BioCep Ltd.

BioCep's rare cell separation capabilities will allow novel therapy developments such as non-invasive prenatal diagnosis in the 1st trimest

  • Stage Concept Only
  • Industry Biotechnology
  • Location Safed, IL
  • Currency USD
  • Employees 8
  • Website

Company Summary

BioCep has developed a novel cell separation technology for rare cell isolation facilitating development of novel clinical applications such as prenatal diagnosis, stem cell therapies and disease management. BioCep will market application-specific systems and consumable kits to customers in these fields. BioCEP will partner with entities to develop these various groundbreaking applications. Sales of BioCEP's R&D cell isolation device has begun.


  • Default avatar
    Doron Birger
    Chairman of the Board

  • Default avatar
    Hannoch Marksheid

  • Default avatar
    Aharon Lamish
    Cheif Engineer

  • Default avatar
    Ofer Klein
    Cheif Scientist

  • Default avatar
    Rachel Leibovitze
    Business Development Manager